Oxford Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
2018
Q4
$530K Buy
2017
Q4
Sell
2017
Q3
$318K Sell
2017
Q2
$303K Buy
2016
Q1
Sell
2015
Q4
$173K Buy